NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Nested Therapeutics

Nested Therapeutics

Private
Cambridge, MassachusettsHealthcare & Life Scienceshttps://nestedtx.com/

Last Round

Series A

Oct 6, 2022

Total Funding Raised

$160M

Company Overview

Nested Therapeutics is a biotechnology company that develops precision oncology therapies by identifying new driver mutations and creating targeted small-molecule medications through advanced genomic and computational techniques.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Infrastructure

Keywords

precision medicinedrug discoverymolecular glueRAS/MAPK pathwaycomputational drug discoveryAI drug discoverysmall-molecule inhibitorsbrain-penetrant therapiesbiotechinvestigational new drugINDoncology researchDNA-encoded libraryin silico drug designprotein degradation

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nested Therapeutics Comparables

Compare Nested Therapeutics with similar companies based on industry and business-model similarity.

Nested Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
TRIANA Biomedicines
78%
Erasca
77%
Orionis Biosciences
76%

Nested Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AOct 6, 2022
SeedDec 1, 2021

Key People

Founding team and executive leadership

Darrin Miles

President Chief Executive Officer

Executive Team

Nested Therapeutics Investors

Notable investors and investment history

Nested Therapeutics investors
InvestorRounds
S32Series A
Avidity Partners ManagementSeries A
TD SecuritiesSeries A
Blue Owl CapitalSeries A
Goldman Sachs Asset Management Private EquitySeries A
Avidity PartnersSeries A
Foresite CapitalSeries A

Nested Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Nested Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Nested Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersCambridge, Massachusetts
Employee Range16
Year Founded2021
Last FundingOct 6, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.